Phase
Condition
Leukemia
Blood Cancer
White Cell Disorders
Treatment
LLS Program
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Be currently receiving primary or relapse treatment for a diagnosis of leukemia,lymphoma, myeloma, myelodysplastic syndromes (MDS), or myeloproliferative neoplasms (MPN)
Report experiencing at least one unmet need addressed by the LLS Program (i.e.,medical care including second opinions, travel for care, clinical trial access,financial and insurance needs, supportive programs, disease and treatment education)
Not be currently participating in any LLS programs or services
Be willing to be followed for 6 months
Speak English or Spanish
Exclusion
Exclusion Criteria:
Are not receiving primary or relapse treatment for a diagnosis of leukemia,lymphoma, myeloma, myelodysplastic syndromes (MDS), or myeloproliferative neoplasms (MPN)
Are not experiencing unmet needs addressed by the LLS Program (i.e., medical careincluding second opinions, travel for care, clinical trial access, financial andinsurance needs, supportive programs, disease and treatment education)
Are currently participating in any LLS programs or services
Are not willing to be followed for 6 months
Do not speak English or Spanish.
Study Design
Connect with a study center
Sylvester Comprehensive Cancer Center
Miami, Florida 33136
United StatesActive - Recruiting
University of Chicago Comprehensive Cancer Center
Chicago, Illinois 60637
United StatesSite Not Available
Mays Cancer Center at UT Health San Antonio
San Antonio, Texas 78229
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.